Ajay Srivastava, CEO of Dimensions Consulting told CNBC-TV18, "Sun Pharma is a given. It's a good buy. I would still buy Coal India because pricing parity-wise they are still way off globally. It's a quality asset, it’s a quality company, and it has got huge cash reserves. So, whenever they get to a petroleum company kind of a pass through environment, they will perform well."
He further added, "For Tata Motors, demand is collapsing here, but globally they are doing better so it's a trade off call. I would not put my money there. IndusInd Bank is priced quite highly. It would had got a run up of 25 percent last year and the verdict is out whether they will continue to do 25 percent. I would not believe that the price will go up another 25 percent, so, I would stay clear of it. However, Coal India is a quality asset, we should definitely buy it. Sun Pharma, if you have it, keep it going.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!